These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15610190)

  • 1. Clobazam as a new antiepileptic drug and clorazepate dipotassium as an alternative antiepileptic drug in Japan.
    Sugai K
    Epilepsia; 2004; 45 Suppl 8():20-5. PubMed ID: 15610190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.
    Montenegro MA; Arif H; Nahm EA; Resor SR; Hirsch LJ
    Clin Neuropharmacol; 2008; 31(6):333-8. PubMed ID: 19050410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobazam in the treatment of epilepsy: a review of the literature.
    Remy C
    Epilepsia; 1994; 35 Suppl 5():S88-91. PubMed ID: 8039479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB.
    Kinoshita M; Ikeda A; Begum T; Terada K; Shibasaki H
    J Neurol Sci; 2007 Dec; 263(1-2):44-8. PubMed ID: 17588610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of clobazam for the treatment of refractory complex partial seizures.
    Shimizu H; Kawasaki J; Yuasa S; Tarao Y; Kumagai S; Kanemoto K
    Seizure; 2003 Jul; 12(5):282-6. PubMed ID: 12810340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year.
    Mills JK; Lewis TG; Mughal K; Ali I; Ugur A; Whitehouse WP
    Seizure; 2011 Jun; 20(5):402-5. PubMed ID: 21414810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy.
    Montenegro MA; Cendes F; Noronha AL; Mory SB; Carvalho MI; Marques LH; Guerreiro CA
    Epilepsia; 2001 Apr; 42(4):539-42. PubMed ID: 11440350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
    Lee EH; Yum MS; Choi HW; Ko TS
    Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance.
    Singh A; Guberman AH; Boisvert D
    Epilepsia; 1995 Aug; 36(8):798-803. PubMed ID: 7635098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up.
    Türkdoğan D; Öztürk G
    Acta Neurol Belg; 2022 Feb; 122(1):51-57. PubMed ID: 33782854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobazam in the treatment of Lennox-Gastaut syndrome.
    Conry JA; Ng YT; Paolicchi JM; Kernitsky L; Mitchell WG; Ritter FJ; Collins SD; Tracy K; Kormany WN; Abdulnabi R; Riley B; Stolle J
    Epilepsia; 2009 May; 50(5):1158-66. PubMed ID: 19170737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
    Geffrey AL; Pollack SF; Bruno PL; Thiele EA
    Epilepsia; 2015 Aug; 56(8):1246-51. PubMed ID: 26114620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
    Cao D; Ohtani H; Ogiwara I; Ohtani S; Takahashi Y; Yamakawa K; Inoue Y
    Epilepsia; 2012 Jul; 53(7):1140-5. PubMed ID: 22578034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic effect and serum levels of clorazepate on children with refractory seizures.
    Mimaki T; Tagawa T; Ono J; Tanaka J; Terada H; Itoh N; Yabuuchi H
    Brain Dev; 1984; 6(6):539-44. PubMed ID: 6152517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy.
    Klehm J; Thome-Souza S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Kadish NE; Libenson M; Peters J; Poduri A; Rotenberg A; Takeoka M; Bourgeois B; Loddenkemper T
    Pediatr Neurol; 2014 Jul; 51(1):60-6. PubMed ID: 24830765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clobazam therapy of refractory epilepsy in tuberous sclerosis complex.
    Jennesson M; van Eeghen AM; Caruso PA; Paolini JL; Thiele EA
    Epilepsy Res; 2013 May; 104(3):269-74. PubMed ID: 23219029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.